News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Viswanathan Ravi
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2022 |
4
| NewView Capital Fund I, L.P. (10% Owner) has filed a Form 4 on Duolingo, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0
Acquired 11,466 shares
@ $0
Disposed of 11,466 shares
@ $0
Acquired 2,200 shares
@ $0 |
|
| 06/28/2022 |
4
| NewView Capital Fund I, L.P. (10% Owner) has filed a Form 4 on Duolingo, Inc.|
Txns:
| Disposed of 500,000 shares
@ $0
Acquired 5,733 shares
@ $0
Disposed of 5,733 shares
@ $0
Acquired 1,097 shares
@ $0 |
|
| 03/25/2022 |
4
| NewView Capital Fund I, L.P. (10% Owner) has filed a Form 4 on Duolingo, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0
Acquired 11,467 shares
@ $0
Disposed of 11,467 shares
@ $0
Acquired 2,194 shares
@ $0 |
|
| 02/16/2022 |
4
| NewView Capital Fund I, L.P. (10% Owner) has filed a Form 4 on Duolingo, Inc.|
Txns:
| Disposed of 500,000 shares
@ $0
Acquired 5,732 shares
@ $0
Disposed of 5,732 shares
@ $0
Acquired 1,096 shares
@ $0 |
|
| 02/16/2022 |
4
| NewView Capital Fund I, L.P. (10% Owner) has filed a Form 4 on Duolingo, Inc.|
Txns:
| Converted 5,239,835 shares
@ $0
Converted 5,239,835 options to buy
@ $0 |
|
| 07/27/2021 |
3
| NewView Capital Fund I, L.P. (10% Owner) has filed a Form 3 on Duolingo, Inc. |
| 10/24/2018 |
4
| NEW ENTERPRISE ASSOCIATES 13 LP (10% Owner) has filed a Form 4 on PhaseBio Pharmaceuticals Inc|
Txns:
| Converted 4,841,634 shares
@ $0
Bought 1,800,000 shares
@ $5, valued at
$9M
Exercised (in-or-at-the-money) 49,030 options to buy
@ $0.12, valued at
$5.9k
Exercised (in-or-at-the-money) 49,030 preferred shares
@ $0.12, valued at
$5.9k
Sold 1,177 preferred shares
@ $5, valued at
$5.9k
Converted 3,279,627 preferred shares
@ $0
Exercised (in-or-at-the-money) 181,190 options to buy
@ $0.12, valued at
$21.7k
Exercised (in-or-at-the-money) 181,190 preferred shares
@ $0.12, valued at
$21.7k
Sold 4,349 preferred shares
@ $5, valued at
$21.7k
Converted 437,706 preferred shares
@ $0
Converted 1,124,301 preferred shares
@ $0 |
|
| 10/18/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/17/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/10/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Elastic N.V.|
Txns:
| Converted 4,155,995 shares
@ $0
Converted 1,528,117 shares
@ $0
Converted 4,155,995 options to buy
@ $0
Converted 1,528,117 options to buy
@ $0 |
|
| 10/04/2018 |
3
| Viswanathan Ravi (10% Owner) has filed a Form 3 on Elastic N.V. |
| 09/10/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Bought 3,000,000 shares
@ $1.6667, valued at
$5M
Bought 12,000,000 shares
@ $1.6667, valued at
$20M
|
|
| 08/22/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 663,716 shares
@ $2.26, valued at
$1.5M
|
|
| 07/20/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 200,000 shares
@ $1.9529, valued at
$390.6k
Bought 50,600 shares
@ $1.9993, valued at
$101.2k
|
|
| 06/28/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 5,295 shares
@ $2.15, valued at
$11.4k
Bought 187,130 shares
@ $2.0985, valued at
$392.7k
|
|
| 05/30/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 275 shares
@ $2.15, valued at
$591.3 |
|
| 05/30/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 416,666 shares
@ $4, valued at
$1.7M
Granted 416,667 shares
@ $4, valued at
$1.7M
|
|
| 05/21/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 184,179 shares
@ $2.1253, valued at
$391.4k
Bought 20,100 shares
@ $2.1357, valued at
$42.9k
Bought 32,200 shares
@ $2.1447, valued at
$69.1k
|
|
| 05/10/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 70,873 shares
@ $2.1341, valued at
$151.3k
|
|
| 05/09/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on MULESOFT, INC|
Txns:
| Converted 12,679,970 shares
@ $0
Unknown transaction of 12,679,970 shares
@ $0
Converted 2,576,939 shares
@ $0
Unknown transaction of 2,576,939 shares
@ $0
Converted 858,978 shares
@ $0
Unknown transaction of 858,978 shares
@ $0
Converted 12,679,970 options to buy
@ $0
Converted 2,576,939 options to buy
@ $0
Converted 858,978 options to buy
@ $0 |
|
| 04/23/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2018 |
3
| Viswanathan Ravi (10% Owner) has filed a Form 3 on Surface Oncology, Inc. |
| 04/10/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on AVEO PHARMACEUTICALS INC|
Txns:
| Bought 685,676 shares
@ $2.2415, valued at
$1.5M
Bought 32,100 shares
@ $2.433, valued at
$78.1k
Bought 203,200 shares
@ $2.4606, valued at
$500k
|
|
| 03/28/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Bought 571,164 shares
@ $1.9041, valued at
$1.1M
Bought 6,000,000 shares
@ $1.9167, valued at
$11.5M
|
|
| 03/27/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Tracon Pharmaceuticals, Inc.|
Txns:
| Bought 707,964 shares
@ $2.7, valued at
$1.9M
Bought 707,964 options to buy
@ $2.7, valued at
$1.9M
|
|
| 03/23/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Bought 104,844 shares
@ $1.8105, valued at
$189.8k
Bought 869,574 shares
@ $1.904, valued at
$1.7M
Bought 294,090 shares
@ $1.9462, valued at
$572.4k
|
|
| 03/13/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 10,882,574 shares
@ $0 |
|
| 03/06/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on TESARO, Inc.|
Txns:
| Bought 26,304 shares
@ $54.3216, valued at
$1.4M
Bought 6,399 shares
@ $55.0094, valued at
$352k
Bought 4,080 shares
@ $56.6604, valued at
$231.2k
Bought 17,859 shares
@ $57.3444, valued at
$1M
Bought 30,321 shares
@ $58.2815, valued at
$1.8M
Bought 1,600 shares
@ $59.146, valued at
$94.6k
Bought 17,248 shares
@ $59.7642, valued at
$1M
Bought 12,634 shares
@ $59.8154, valued at
$755.7k
Bought 6,575 shares
@ $54.3216, valued at
$357.2k
Bought 1,600 shares
@ $55.0094, valued at
$88k
Bought 1,020 shares
@ $56.6604, valued at
$57.8k
|
|
| 02/22/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Converted 1,818,000 shares
@ $3.3, valued at
$6M
Converted 1,818,000 preferred shares
@ $3.3, valued at
$6M
|
|
| 02/21/2018 |
4
| NEW ENTERPRISE ASSOCIATES 13 LP (10% Owner) has filed a Form 4 on Ra Pharmaceuticals, Inc.|
Txns:
| Bought 2,000,000 shares
@ $6, valued at
$12M
|
|
| 02/15/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on APPIAN CORP|
Txns:
| Converted 2,724,202 shares
@ $0
Disposed of 2,724,202 shares
@ $0
Acquired 27,242 shares
@ $0
Disposed of 27,242 shares
@ $0
Acquired 13,621 shares
@ $0
Disposed of 13,621 shares
@ $0
Acquired 1,014 shares
@ $0
Acquired 509 shares
@ $0
Converted 2,724,202 options to buy
@ $0 |
|
| 01/26/2018 |
4
| Viswanathan Ravi (10% Owner) has filed a Form 4 on SYNLOGIC, INC.|
Txns:
| Granted 410,000 shares
@ $9.75, valued at
$4M
|
|
| 01/23/2018 |
3
| Viswanathan Ravi (10% Owner) has filed a Form 3 on GENOCEA BIOSCIENCES, INC. |
| 01/09/2018 |
3
| Viswanathan Ravi (10% Owner) has filed a Form 3 on Strongbridge Biopharma plc |
|
|
|